About International Flavors & Fragrances Inc.
https://www.iff.comInternational Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments.
CEO
Jon Erik Fyrwald
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1994-01-20 | Forward | 3:1 |
| 1974-12-17 | Forward | 51:50 |
ETFs Holding This Stock
Summary
Showing Top 3 of 643
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
B of A Securities
Buy
Argus Research
Buy
Citigroup
Buy
Tigress Financial
Buy
Stifel
Buy
Mizuho
Outperform
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
DODGE & COX
Shares:36.97M
Value:$2.59B
VANGUARD GROUP INC
Shares:31.13M
Value:$2.18B
FREEMONT CAPITAL PTE LTD
Shares:25.36M
Value:$1.78B
Summary
Showing Top 3 of 990
About International Flavors & Fragrances Inc.
https://www.iff.comInternational Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.69B ▼ | $757M ▼ | $40M ▼ | 1.48% ▼ | $0.16 ▼ | $351M ▼ |
| Q2-2025 | $2.76B ▼ | $832M ▼ | $612M ▲ | 22.14% ▲ | $2.39 ▲ | $837M ▲ |
| Q1-2025 | $2.84B ▲ | $1.94B ▲ | $-1.02B ▼ | -35.81% ▼ | $-3.98 ▼ | $-687M ▼ |
| Q4-2024 | $2.77B ▼ | $853M ▲ | $-46M ▼ | -1.66% ▼ | $-0.18 ▼ | $197M ▼ |
| Q3-2024 | $2.92B | $803M | $59M | 2.02% | $0.23 | $417M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $773M ▼ | $25.77B ▼ | $11.49B ▼ | $14.24B ▼ |
| Q2-2025 | $816M ▲ | $26.12B ▼ | $11.69B ▼ | $14.4B ▲ |
| Q1-2025 | $613M ▲ | $28.27B ▼ | $15.05B ▲ | $13.18B ▼ |
| Q4-2024 | $469M ▼ | $28.67B ▼ | $14.76B ▼ | $13.88B ▼ |
| Q3-2024 | $567M | $29.93B | $15.12B | $14.78B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $40M ▼ | $164M ▼ | $-115M ▼ | $-237M ▲ | $-195M ▼ | $30M ▼ |
| Q2-2025 | $612M ▲ | $241M ▲ | $2.7B ▲ | $-2.82B ▼ | $203M ▲ | $146M ▲ |
| Q1-2025 | $-1.02B ▼ | $127M ▼ | $-157M ▲ | $169M ▲ | $144M ▲ | $-52M ▼ |
| Q4-2024 | $-46M ▼ | $368M ▲ | $-260M ▼ | $-162M ▲ | $-98M ▲ | $208M ▼ |
| Q3-2024 | $60M | $366M | $-78M | $-421M | $-104M | $258M |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Food Ingredients | $0 ▲ | $830.00M ▲ | $800.00M ▼ | $850.00M ▲ |
 Health Biosciences | $450.00M ▲ | $580.00M ▲ | $540.00M ▼ | $580.00M ▲ |
 Pharma Solutions | $230.00M ▲ | $370.00M ▲ | $270.00M ▼ | $100.00M ▼ |
 Scent | $580.00M ▲ | $650.00M ▲ | $610.00M ▼ | $600.00M ▼ |
 Taste | $0 ▲ | $640.00M ▲ | $630.00M ▼ | $630.00M ▲ |
 Nourish | $1.41Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Asia | $670.00M ▲ | $670.00M ▲ | $650.00M ▼ | $620.00M ▼ |
 EMEA | $930.00M ▲ | $950.00M ▲ | $950.00M ▲ | $930.00M ▼ |
 Latin America | $360.00M ▲ | $350.00M ▼ | $360.00M ▲ | $360.00M ▲ |
 North America | $810.00M ▲ | $870.00M ▲ | $800.00M ▼ | $780.00M ▼ |
CEO
Jon Erik Fyrwald
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1994-01-20 | Forward | 3:1 |
| 1974-12-17 | Forward | 51:50 |
ETFs Holding This Stock
Summary
Showing Top 3 of 643
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
B of A Securities
Buy
Argus Research
Buy
Citigroup
Buy
Tigress Financial
Buy
Stifel
Buy
Mizuho
Outperform
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
DODGE & COX
Shares:36.97M
Value:$2.59B
VANGUARD GROUP INC
Shares:31.13M
Value:$2.18B
FREEMONT CAPITAL PTE LTD
Shares:25.36M
Value:$1.78B
Summary
Showing Top 3 of 990